Guillaume Courbon

Saint-etienne-de-valoux, 42023, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Sex-dependent divergence between skeletal and cardiac responses to phosphate load in experimental CKD.

Sex-dependent divergence between skeletal and cardiac responses to phosphate load in experimental CKD.

Journal: Bone
Published: March 23, 2026

Deciphering the molecular landscape of aortic aging: a meta-analysis of bulk RNA sequencing studies in mice.

Deciphering the molecular landscape of aortic aging: a meta-analysis of bulk RNA sequencing studies in mice.

Journal: GeroScience
Published: November 03, 2025

Site-specific inverse associations between FGF23 levels and marrow adiposity content at the proximal femur in post-menopausal women.

Site-specific inverse associations between FGF23 levels and marrow adiposity content at the proximal femur in post-menopausal women.

Journal: Bone
Published: September 19, 2025

Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case report.

Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case report.

Journal: Joint bone spine
Published: August 25, 2025

FGF23: A player not only in bone diseases.

FGF23: A player not only in bone diseases.

Journal: Joint bone spine
Published: August 12, 2025

Critical Review of Hearing Rehabilitation in Pediatric Oncology: Specific Considerations and Barriers.

Critical Review of Hearing Rehabilitation in Pediatric Oncology: Specific Considerations and Barriers.

Journal: Current oncology (Toronto, Ont.)
Published: July 31, 2025

Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis.

Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis.

Journal: Blood
Published: July 01, 2025

Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy.

Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy.

Journal: Kidney international
Published: October 16, 2024

Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy.

Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy.

Journal: Kidney international
Published: October 16, 2024

Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism.

Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism.

Journal: Current opinion in nephrology and hypertension
Published: April 25, 2024

Post-ischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis.

Post-ischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis.

Journal: bioRxiv : the preprint server for biology
Published: October 24, 2023

Postischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis.

Postischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis.

Journal: The Journal of clinical investigation
Published: October 02, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026